causal
Clinical Benefit Magnitude Is Hardest to Predict
The dimension investors most often get wrong is the magnitude of clinical benefit, because clinical benefit is not black and white and a drug must be meaningfully differentiated from existing or slightly-worse competitors to succeed in a competitive market.
causalpending
Speaker
Tal ZaksEvidence Quote
“the one that we get probably the most wrong is the one that is still the hardest to predict, which is what is the magnitude of clinical benefit that this will bring?”
Created: 11/19/2026, 4:01:33 PM
Your notes
Loading notes...